VEGF-A has been recognized as a significant pro-angiogenic factor, with its expression alterations and structural modifications being implicated in cancer progression and associated with patients’ overall survival and treatment response (Elebiyo et al. 2022; Al Kawas et al. 2022). The gene discussed is VEGFA; the disease is cancer.